Epidermal growth factor receptor (EGFR), for instance, was demonstrated to enhance its oncogenic role in cancer progression by suppressing microRNA (miRNA) maturation of tumor suppressors when associated with phosphorylated AGO2 under hypoxia [24,25]. The gene discussed is EGFR; the disease is neoplasm.